Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,621
archived clinical trials in
Urology

Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence
An Investigation of the Treatment of Fecal Incontinence Using the TOPAS Sling System For Women (TRANSFORM)
Status: Enrolling
Updated:  12/11/2015
Cleveland Clinic Foundation - Ohio
mi
from
Cleveland, OH
Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence
An Investigation of the Treatment of Fecal Incontinence Using the TOPAS Sling System For Women (TRANSFORM)
Status: Enrolling
Updated: 12/11/2015
Cleveland Clinic Foundation - Ohio
mi
from
Cleveland, OH
Click here to add this to my saved trials
Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence
An Investigation of the Treatment of Fecal Incontinence Using the TOPAS Sling System For Women (TRANSFORM)
Status: Enrolling
Updated:  12/11/2015
University of Oklahoma
mi
from
Oklahoma City, OK
Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence
An Investigation of the Treatment of Fecal Incontinence Using the TOPAS Sling System For Women (TRANSFORM)
Status: Enrolling
Updated: 12/11/2015
University of Oklahoma
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence
An Investigation of the Treatment of Fecal Incontinence Using the TOPAS Sling System For Women (TRANSFORM)
Status: Enrolling
Updated:  12/11/2015
Womens Hospital of Texas
mi
from
Houston, TX
Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence
An Investigation of the Treatment of Fecal Incontinence Using the TOPAS Sling System For Women (TRANSFORM)
Status: Enrolling
Updated: 12/11/2015
Womens Hospital of Texas
mi
from
Houston, TX
Click here to add this to my saved trials
Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence
An Investigation of the Treatment of Fecal Incontinence Using the TOPAS Sling System For Women (TRANSFORM)
Status: Enrolling
Updated:  12/11/2015
Sacred Heart Medical Center
mi
from
Spokane, WA
Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence
An Investigation of the Treatment of Fecal Incontinence Using the TOPAS Sling System For Women (TRANSFORM)
Status: Enrolling
Updated: 12/11/2015
Sacred Heart Medical Center
mi
from
Spokane, WA
Click here to add this to my saved trials
Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence
An Investigation of the Treatment of Fecal Incontinence Using the TOPAS Sling System For Women (TRANSFORM)
Status: Enrolling
Updated:  12/11/2015
St. Lukes Hospital
mi
from
Allentown, PA
Clinical Study to Investigate the Effectiveness of the TOPAS System to Treat Fecal Incontinence
An Investigation of the Treatment of Fecal Incontinence Using the TOPAS Sling System For Women (TRANSFORM)
Status: Enrolling
Updated: 12/11/2015
St. Lukes Hospital
mi
from
Allentown, PA
Click here to add this to my saved trials
Comparing Oxygen Saturation in Post Anesthesia Care Unit After Different Methods of Pain Relief
Oxygen Saturation During Transfer From Operating Room to Post Anesthesia Care Unit After Current Anesthesia Care
Status: Enrolling
Updated:  12/11/2015
University of Texas,Anesthesiology Department
mi
from
Houston, TX
Comparing Oxygen Saturation in Post Anesthesia Care Unit After Different Methods of Pain Relief
Oxygen Saturation During Transfer From Operating Room to Post Anesthesia Care Unit After Current Anesthesia Care
Status: Enrolling
Updated: 12/11/2015
University of Texas,Anesthesiology Department
mi
from
Houston, TX
Click here to add this to my saved trials
Intranasal Oxytocin for the Treatment of Pain Associated With Interstitial Cystitis
Intranasal Oxytocin for the Treatment of Pain Associated With Interstitial Cystitis
Status: Enrolling
Updated:  12/14/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Intranasal Oxytocin for the Treatment of Pain Associated With Interstitial Cystitis
Intranasal Oxytocin for the Treatment of Pain Associated With Interstitial Cystitis
Status: Enrolling
Updated: 12/14/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
mi
from
Birmingham, AL
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
mi
from
Phoenix, AZ
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
mi
from
Stanford, CA
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
mi
from
Stanford, CA
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
mi
from
Sarasota, FL
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
mi
from
St. Petersburg, FL
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
mi
from
Meridian, ID
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
mi
from
Meridian, ID
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
mi
from
Kansas City, KA
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
mi
from
Grand Rapids, MI
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
mi
from
Jackson, MI
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
mi
from
Jackson, MI
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
mi
from
Plymouth, MN
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
mi
from
Plymouth, MN
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
mi
from
Woodbury, MN
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
mi
from
Woodbury, MN
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
mi
from
Brick, NJ
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
mi
from
Brick, NJ
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
mi
from
Cleveland, OH
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
mi
from
Columbus, OH
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
mi
from
Arlington, TX
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
mi
from
Arlington, TX
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
mi
from
Carrolton, TX
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
mi
from
Carrolton, TX
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
mi
from
Dallas, TX
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated:  12/16/2015
Clinical Research Facility
mi
from
Temple, TX
InSite for Over Active Bladder
Prospective, Multicenter Trial Evaluating the Safety and Efficacy of InterStim® Therapy in Subjects With Symptoms of Overactive Bladder (InSite OAB)
Status: Enrolling
Updated: 12/16/2015
Clinical Research Facility
mi
from
Temple, TX
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Alliance Urology Specialists
mi
from
Greensboro, NC
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Alliance Urology Specialists
mi
from
Greensboro, NC
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Carolina Urologic Research Center
mi
from
Myrtle Beach, SC
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Carolina Urologic Research Center
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Citrus Valley Medical Research, Inc.
mi
from
Glendora, CA
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Citrus Valley Medical Research, Inc.
mi
from
Glendora, CA
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Female Pelvic Medicine & Urogynecology Institute of MI
mi
from
Grand Rapids, MI
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Female Pelvic Medicine & Urogynecology Institute of MI
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Medical University of South Carolina
mi
from
Charleston, SC
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
MetroHealth Med Ctr
mi
from
Cleveland, OH
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Premier Medical Group of the Hudson Valley
mi
from
Poughkeepsie, NY
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Premier Medical Group of the Hudson Valley
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Premier Medical Group of the Hudson Valley PC
mi
from
Newburgh, NY
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Premier Medical Group of the Hudson Valley PC
mi
from
Newburgh, NY
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
The UrogynecologyCenter, LLC
mi
from
Overland Park, KA
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
The UrogynecologyCenter, LLC
mi
from
Overland Park, KA
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Volunteer Research Group, University of Tennessee Medical Center
mi
from
Knoxville, TN
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Volunteer Research Group, University of Tennessee Medical Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
William Beaumont Hospitals
mi
from
Royal Oak, MI
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
William Beaumont Hospitals
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Atlantic Urological Associates
mi
from
Daytona Beach, FL
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Atlantic Urological Associates
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
North Shore - Long Island Jewish Heath System - Monter Cancer Center
mi
from
New Hyde Park, NY
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
North Shore - Long Island Jewish Heath System - Monter Cancer Center
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated:  12/16/2015
Exdeo Clinical Research Inc.
mi
from
Abbotsford,
Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating Safety, Tolerability and Efficacy of LiRIS® 400 mg in Women With Interstitial Cystitis Followed by an Open Label Extension
Status: Enrolling
Updated: 12/16/2015
Exdeo Clinical Research Inc.
mi
from
Abbotsford,
Click here to add this to my saved trials
Urology Database to Evaluate Clinical Information and Improve Patient Care.
Urology Database for Outcomes Research
Status: Enrolling
Updated:  12/22/2015
William Beaumont Hospital
mi
from
Royal Oak, MI
Urology Database to Evaluate Clinical Information and Improve Patient Care.
Urology Database for Outcomes Research
Status: Enrolling
Updated: 12/22/2015
William Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Overactive Bladder Education
Overactive Bladder Education
Status: Enrolling
Updated:  12/29/2015
Hartford Hospital, Urogynecology Division
mi
from
Glastonbury, CT
Overactive Bladder Education
Overactive Bladder Education
Status: Enrolling
Updated: 12/29/2015
Hartford Hospital, Urogynecology Division
mi
from
Glastonbury, CT
Click here to add this to my saved trials
Overactive Bladder Education
Overactive Bladder Education
Status: Enrolling
Updated:  12/29/2015
Hartford Hospital, Urogynecology Division
mi
from
Hartford, CT
Overactive Bladder Education
Overactive Bladder Education
Status: Enrolling
Updated: 12/29/2015
Hartford Hospital, Urogynecology Division
mi
from
Hartford, CT
Click here to add this to my saved trials
Overactive Bladder Education
Overactive Bladder Education
Status: Enrolling
Updated:  12/29/2015
Hartford Hospital, Urogynecology Division
mi
from
West Hartford, CT
Overactive Bladder Education
Overactive Bladder Education
Status: Enrolling
Updated: 12/29/2015
Hartford Hospital, Urogynecology Division
mi
from
West Hartford, CT
Click here to add this to my saved trials
Urinary Continence Index for Prediction of Urinary Incontinence in Older Women
Urinary Continence Index for Prediction of Urinary Incontinence in Older Women
Status: Enrolling
Updated:  1/5/2016
Oakland University
mi
from
Rochester, MI
Urinary Continence Index for Prediction of Urinary Incontinence in Older Women
Urinary Continence Index for Prediction of Urinary Incontinence in Older Women
Status: Enrolling
Updated: 1/5/2016
Oakland University
mi
from
Rochester, MI
Click here to add this to my saved trials
Urinary Continence Index for Prediction of Urinary Incontinence in Older Women
Urinary Continence Index for Prediction of Urinary Incontinence in Older Women
Status: Enrolling
Updated:  1/5/2016
William Beaumont Hospital
mi
from
Royal Oak, MI
Urinary Continence Index for Prediction of Urinary Incontinence in Older Women
Urinary Continence Index for Prediction of Urinary Incontinence in Older Women
Status: Enrolling
Updated: 1/5/2016
William Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Further Enhancing Non-pharmacologic Therapy for Incontinence
Further Enhancing Non-pharmacologic Therapy for Incontinence
Status: Enrolling
Updated:  1/7/2016
Geriatric Continence Research Unit, NE547 Montefiore UPMC
mi
from
Pittsburgh, PA
Further Enhancing Non-pharmacologic Therapy for Incontinence
Further Enhancing Non-pharmacologic Therapy for Incontinence
Status: Enrolling
Updated: 1/7/2016
Geriatric Continence Research Unit, NE547 Montefiore UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices
Assessing the Impact of Low-Touch Devices on Medication Adherence
Status: Enrolling
Updated:  1/7/2016
CVS Health
mi
from
Woonsocket, RI
Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices
Assessing the Impact of Low-Touch Devices on Medication Adherence
Status: Enrolling
Updated: 1/7/2016
CVS Health
mi
from
Woonsocket, RI
Click here to add this to my saved trials